
51 - 200 employees
Founded 2024
🔥 Funding within the last year
💰 $600M Series B - Kailera Therapeutics on 2025-10
Kailera Therapeutics (Kailera) is developing a broad, advanced, and differentiated portfolio of clinical-stage injectable and oral therapies for the treatment of obesity. Kailera’s most advanced program, KAI-9531 (being developed in China as HRS9531), is an injectable GLP-1/GIP receptor dual agonist that demonstrated positive clinical trial results in obesity in China. The Company is also advancing a diversified pipeline leveraging several mechanisms and routes of delivery. Kailera’s mission is to develop next-generation weight management therapies that give people the power to transform their lives and elevate their overall health. The Company is based in Waltham, MA and San Diego, CA. For more information, visit www.kailera.com.
Selected: 🆕 Date Added.
🕒 September 4
51 - 200
Senior Director leading clinical data management for Kailera’s obesity and related-condition therapies. Driving global data integrity, regulatory readiness, CRO oversight, and team growth.
🇺🇸 United States – Remote
💵 $241k - $295k / year
🔥 Funding within the last year
💰 $600M Series B - Kailera Therapeutics on 2025-10
⏰ Full Time
🟠 Senior
👨⚕️ Medical Director
👻 Ghost score 0%
🕒 July 29
51 - 200
Medical Science Liaison focusing on strategic partnerships and evidence generation for obesity therapies at Kailera Therapeutics. Building Field Medical Affairs from the ground up.
🤠 Texas – Remote
💵 $196k - $235k / year
🔥 Funding within the last year
💰 $600M Series B - Kailera Therapeutics on 2025-10
⏰ Full Time
🟢 Junior
🟡 Mid-level
✨ Medical Science Liaison
👻 Ghost score 6%
🕒 July 29
51 - 200
Associate Director/Director managing program for regulatory submissions at Kailera Therapeutics. Leading cross-functional teams in drug development and ensuring compliance with marketing authorization filings.
🍂 Massachusetts – Remote
💵 $155k - $235k / year
🔥 Funding within the last year
💰 $600M Series B - Kailera Therapeutics on 2025-10
⏰ Full Time
🟠 Senior
📋 Program Manager
👻 Ghost score 6%
🕒 July 29
51 - 200
Associate Director overseeing analytical development and quality control for Kailera's therapies. Collaborating cross-functionally to ensure drug development and manufacturing alignment with regulatory requirements.
🇺🇸 United States – Remote
💵 $155k - $190k / year
🔥 Funding within the last year
💰 $600M Series B - Kailera Therapeutics on 2025-10
⏰ Full Time
🟠 Senior
👔 Director
👻 Ghost score 6%